Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy.

  • Authors : Schönthal AH; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*therapeutic use ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: British journal of cancer [Br J Cancer] 2007 Dec 03; Vol. 97 (11), pp. 1465-8. Date of Electronic Publication: 2007 Oct 23.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia.

  • Authors : Farooqui M; 1Division of Hematology, Oncology and Transplantation, the Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.; Li Y

Subjects: Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacology ; Mammary Neoplasms, Animal/Mammary Neoplasms, Animal/Mammary Neoplasms, Animal/*prevention & control ; Morphine/Morphine/Morphine/*pharmacology

  • Source: British journal of cancer [Br J Cancer] 2007 Dec 03; Vol. 97 (11), pp. 1523-31. Date of Electronic Publication: 2007 Oct 30.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.

  • Authors : Barnes NL; Department of Academic Surgery, South Manchester University Hospital, Research and Education Building 2nd Floor, Southmoor Road, Wythenshawe, Manchester M23 9LT, UK.; Warnberg F

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*drug effects ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*pharmacology

  • Source: British journal of cancer [Br J Cancer] 2007 Feb 26; Vol. 96 (4), pp. 575-82. Date of Electronic Publication: 2007 Feb 06.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts.

  • Authors : Wang X; Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.; Zhang L

Subjects: Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*drug therapy ; Cyclooxygenase 2/Cyclooxygenase 2/Cyclooxygenase 2/*metabolism ; Indoles/Indoles/Indoles/*therapeutic use

  • Source: British journal of cancer [Br J Cancer] 2013 Feb 05; Vol. 108 (2), pp. 319-26. Date of Electronic Publication: 2013 Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

A nationwide study of aspirin, other non-steroidal anti-inflammatory drugs, and Hodgkin lymphoma risk in Denmark.

  • Authors : Chang ET; Cancer Prevention Institute of California, 2201 Walnut Avenue, Fremont, CA 94538, USA. ; Frøslev T

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*administration & dosage ; Aspirin/Aspirin/Aspirin/*administration & dosage ; Hodgkin Disease/Hodgkin Disease/Hodgkin Disease/*epidemiology

  • Source: British journal of cancer [Br J Cancer] 2011 Nov 22; Vol. 105 (11), pp. 1776-82. Date of Electronic Publication: 2011 Oct 25.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
  • 1-10 ل  78 نتائج ل ""Cyclooxygenase 2 Inhibitors""